ArticleCell death & disease2026

Dual actionability of BMI1 activation and mitotic vulnerability defines adaptive Osimertinib resistance in EGFR-mutant NSCLC.

Paolo Armanetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.